Xiaoli Ding

643 total citations
13 papers, 501 citations indexed

About

Xiaoli Ding is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Xiaoli Ding has authored 13 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Xiaoli Ding's work include Cytokine Signaling Pathways and Interactions (3 papers), MicroRNA in disease regulation (2 papers) and T-cell and B-cell Immunology (2 papers). Xiaoli Ding is often cited by papers focused on Cytokine Signaling Pathways and Interactions (3 papers), MicroRNA in disease regulation (2 papers) and T-cell and B-cell Immunology (2 papers). Xiaoli Ding collaborates with scholars based in China, United States and United Kingdom. Xiaoli Ding's co-authors include Guang‐Xian Zhang, Abdolmohamad Rostami, Bogoljub Ćirić, Yaping Yan, Yuanyuan Lu, Fusheng Chen, Yi He, Wanping Chen, Xiaoxiao Guo and Runfa Chen and has published in prestigious journals such as The Journal of Immunology, Chemical Science and Molecular Therapy.

In The Last Decade

Xiaoli Ding

12 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Ding China 8 222 171 108 89 89 13 501
Kyungha Shin South Korea 13 33 0.1× 33 0.2× 136 1.3× 27 0.3× 16 0.2× 22 355
Chien-Lin Chen Taiwan 13 17 0.1× 112 0.7× 257 2.4× 50 0.6× 22 0.2× 21 513
You-Jin Lee South Korea 16 20 0.1× 55 0.3× 375 3.5× 15 0.2× 30 0.3× 25 621
Ruijun Wang China 9 18 0.1× 43 0.3× 130 1.2× 9 0.1× 41 0.5× 24 406
Xingyi Zhang China 16 18 0.1× 59 0.3× 395 3.7× 25 0.3× 72 0.8× 29 648
Xiyu Mei China 11 8 0.0× 83 0.5× 231 2.1× 28 0.3× 48 0.5× 15 518
Genyun Tang China 13 18 0.1× 43 0.3× 167 1.5× 84 0.9× 14 0.2× 23 405
Shao‐Ming Wang Taiwan 16 7 0.0× 73 0.4× 351 3.3× 28 0.3× 103 1.2× 27 620
Ruixia Deng Hong Kong 11 6 0.0× 47 0.3× 181 1.7× 49 0.6× 37 0.4× 18 501

Countries citing papers authored by Xiaoli Ding

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ding more than expected).

Fields of papers citing papers by Xiaoli Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ding. The network helps show where Xiaoli Ding may publish in the future.

Co-authorship network of co-authors of Xiaoli Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Ding. A scholar is included among the top collaborators of Xiaoli Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Ding. Xiaoli Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Zhang, Yaling, Huanhuan Song, Cheng Guo, et al.. (2024). Isoliquiritigenin alleviates experimental autoimmune encephalomyelitis by modulating inflammatory and neuroprotective reactive astrocytes. Biomedicine & Pharmacotherapy. 178. 117188–117188. 4 indexed citations
3.
Hu, Wang, Jun Wen, Yang Yang, et al.. (2022). Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study. Frontiers in Pharmacology. 13. 1036208–1036208. 3 indexed citations
5.
Tian, Lili, Wenli Zhu, Yuanchu Liu, et al.. (2019). Neural Stem Cells Transfected with Leukemia Inhibitory Factor Promote Neuroprotection in a Rat Model of Cerebral Ischemia. Neuroscience Bulletin. 35(5). 901–908. 23 indexed citations
6.
Gong, Ye, Yuanchu Liu, Xiaoli Ding, et al.. (2019). Tanshinone IIA Ameliorates CNS Autoimmunity by Promoting the Differentiation of Regulatory T Cells. Neurotherapeutics. 17(2). 690–703. 19 indexed citations
7.
Chen, Wanping, Runfa Chen, Qingpei Liu, et al.. (2017). Orange, red, yellow: biosynthesis of azaphilone pigments in Monascus fungi. Chemical Science. 8(7). 4917–4925. 245 indexed citations
8.
Ding, Xiaoli, Fang Cao, Langjun Cui, et al.. (2015). IL-9 signaling affects central nervous system resident cells during inflammatory stimuli. Experimental and Molecular Pathology. 99(3). 570–574. 44 indexed citations
9.
Ding, Xiaoli, Yaping Yan, Xing Li, et al.. (2015). Silencing IFN-γ Binding/Signaling in Astrocytes versus Microglia Leads to Opposite Effects on Central Nervous System Autoimmunity. The Journal of Immunology. 194(9). 4251–4264. 58 indexed citations
10.
Yan, Ruifang, et al.. (2014). Platelet-derived growth factor-β expression in rabbit models of cerebral vasospasm following subarachnoid hemorrhage. Molecular Medicine Reports. 10(3). 1416–1422. 11 indexed citations
11.
Qin, Haixia, et al.. (2013). Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo. Cytotechnology. 65(4). 643–653. 13 indexed citations
12.
Ding, Xiaoli. (2013). A temporary self-expanding metallic stent for malignant colorectal obstruction. World Journal of Gastroenterology. 19(7). 1119–1119. 5 indexed citations
13.
Yan, Yaping, Xiaoli Ding, Ke Li, et al.. (2012). CNS-specific Therapy for Ongoing EAE by Silencing IL-17 Pathway in Astrocytes. Molecular Therapy. 20(7). 1338–1348. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026